{"id":9226,"date":"2021-07-28T16:37:47","date_gmt":"2021-07-28T16:37:47","guid":{"rendered":"https:\/\/www.kolabtree.com\/blog\/?p=9226"},"modified":"2023-02-15T11:44:54","modified_gmt":"2023-02-15T11:44:54","slug":"how-to-prepare-a-risk-management-plan-rmp-an-essential-guide","status":"publish","type":"post","link":"https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/","title":{"rendered":"How to prepare a Risk Management Plan (RMP): An essential guide"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_45_1 counter-flat ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\">Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" area-label=\"ez-toc-toggle-icon-1\"><label for=\"item-69f31fd8a4eae\" aria-label=\"Table of Content\"><span style=\"display: flex;align-items: center;width: 35px;height: 30px;justify-content: center;direction:ltr;\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/label><input  type=\"checkbox\" id=\"item-69f31fd8a4eae\"><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/#Abbreviations\" title=\"Abbreviations\">Abbreviations<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/#Purpose_Scope_of_a_Risk_Management_Plan\" title=\"Purpose &amp; Scope of a Risk Management Plan\">Purpose &amp; Scope of a Risk Management Plan<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/#Requirements_of_an_RMP\" title=\"Requirements of an RMP\n\">Requirements of an RMP\n<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/#European_Risk_Management_Plan_Model\" title=\"European Risk Management Plan Model\">European Risk Management Plan Model<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/#List_for_writing_or_evaluating_an_RMP\" title=\"List for writing or evaluating an RMP\">List for writing or evaluating an RMP<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/#Plan_of_Pharmacovigilance\" title=\"Plan of Pharmacovigilance\">Plan of Pharmacovigilance<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/#Post-authorization_efficacy_studies_plan\" title=\"Post-authorization efficacy studies plan\">Post-authorization efficacy studies plan<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/#Risk_mitigation_plan\" title=\"Risk mitigation plan\">Risk mitigation plan<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/#Summary_for_Risk_management_plan\" title=\"Summary for Risk management plan\">Summary for Risk management plan<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/#United_State_FDA_General_quality_Risk_Management_Process\" title=\"United State (FDA) General quality Risk Management Process\">United State (FDA) General quality Risk Management Process<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/#Main_Responsibilities\" title=\"Main Responsibilities\">Main Responsibilities<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/#Initiating_a_Quality_Risk_Management_Process_QRMP\" title=\"Initiating a Quality Risk Management Process (QRMP)\">Initiating a Quality Risk Management Process (QRMP)<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/#Assessment_for_Risk\" title=\"Assessment for Risk\">Assessment for Risk<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/#Control_for_Risk\" title=\"Control for Risk\">Control for Risk<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/#Communication_for_Risk\" title=\"Communication for Risk\">Communication for Risk<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/#Review_for_Risk\" title=\"Review for Risk\">Review for Risk<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/#Management_methodology_of_risk\" title=\"Management methodology of risk\">Management methodology of risk<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/#Management_methods_and_tools_of_risk\" title=\"Management methods and tools of risk\">Management methods and tools of risk<\/a><\/li><\/ul><\/nav><\/div>\n<p>Nare Simonyan, freelance <a href=\"https:\/\/www.kolabtree.com\/find-an-expert\/nare-simonyan\/?utm_source=Blog&amp;utm_medium=Post&amp;utm_campaign=RMP\">regulatory affairs specialist<\/a> at Kolabtree, provides a comprehensive guide to preparing a Risk Management Plan (RMP).<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Abbreviations\"><\/span><strong>Abbreviations<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<ul>\n<li>RMP &#8211; Risk Management Plan<\/li>\n<li>aPV &#8211; additional Pharmacovigilance<\/li>\n<li>eCTD &#8211; electronic Common Technical Document<\/li>\n<li>PSUR- Periodic Safety Update Report<\/li>\n<li>PASS &#8211; Post-Authorization Safety Studies<\/li>\n<li>PAES &#8211; Plans Post-authorization Efficacy Studies<\/li>\n<li>RA- Regulatory Authority<\/li>\n<li>QRMP &#8211; Quality Risk Management Process<\/li>\n<li>RMCs &#8211; Risk Management Committees<\/li>\n<li>MAA -Marketing Authorization Application<\/li>\n<li>ADR-Adverse Drug Reactions<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Purpose_Scope_of_a_Risk_Management_Plan\"><\/span><strong>Purpose &amp; Scope of a Risk Management Plan<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>A document summarizing the risks and pharmacovigilance\/risk minimization activities for a medicinal product with a well-established safety profile, used often to support a submission in a country\/region and when the summary format is accepted.<\/p>\n<p>The RMP is internally approved document that represents the company medical position designed to document risk management activities (risk minimization measures and pharmacovigilance) considered necessary to identify, characterize, or mitigate the safety concerns associated with a medicinal product. It serves as a reference risk management document for a given product and is used to communicate company position to appropriate stakeholders worldwide for inclusion in local risk management plans (RMPs). When an approved core RMP (cRMP) is available, the cRMP serves as the reference RMP (rRMP).<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Requirements_of_an_RMP\"><\/span><strong>Requirements of an RMP<br \/>\n<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The product RMPs must:<\/p>\n<ul>\n<li>Be consistent with the product safety information and data sources used in their creation<\/li>\n<li>Reflect the company\u2019s position with regard to:<\/li>\n<\/ul>\n<ol>\n<li>The characterization of safety risks, including safety concerns, likely to have an impact on the benefit-risk balance for a medicinal product (i.e., important risks <span style=\"font-size: 14px;\">and missing information) to necessitate additional pharmacovigilance (aPV) <\/span><span style=\"font-size: 14px;\">activities or non-routine risk minimization activities<\/span><\/li>\n<li>The details of aPV activities or non-routine risk minimization activities.<\/li>\n<\/ol>\n<ul>\n<li>Comply with regulations, including regulated format or timing, applicable to the country\/region for which the RMP is being prepared.<\/li>\n<\/ul>\n<p>When an RA insists that elements of the RMP be different from the company position, thoseelements must be consistent with the specifications provided by or agreed with the RA.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"European_Risk_Management_Plan_Model\"><\/span><strong>European Risk Management Plan Model<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>According to the EMA guideline definition, the risk management plan (RMP) presented as a document for a risk management system. RMP is a document to identify, indicate, and reduce the risks of the medicines.<\/p>\n<p>The RMP model is created based on the relevant points:<\/p>\n<ul>\n<li>Species of safety- authentication of the safety profile of a medicinal product and stress on major identified and major potential risks and not present information, along with safety matter necessary to be addressed in furtherance<\/li>\n<li>Plan of pharmacovigilance \u2013 it is an arrangement of pharmacovigilance action which is intended to find clinically appropriate risks and to verify new adverse drug reactions (ADR)<\/li>\n<li>Risk mitigation plan &#8211; this about planning and execution of risk mitigation<\/li>\n<\/ul>\n<p>This document must be prepared on the basis of scientific knowledge and must not contain any advertising elements. RMP professionals should focus on what information can be important for the readers to realize the safety outline of the medicines.<\/p>\n<p>The MA holder is considered as a responsible person for adding references to the appropriate section of the required documents in eCTD or PSUR, as necessary.<\/p>\n<p>Triggers for the creation or revision of the RMP may include, but are not limited to:<\/p>\n<ul>\n<li>Receipt of a request from a RA<\/li>\n<li>Receipt of a request from Risk Management Committees (RMCs) based on a new or revised product RM strategy<\/li>\n<li>A new or updated marketing authorization application (MAA)<\/li>\n<li>Obtaining and Maintaining Product Marketing Authorizations or license renewal<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"List_for_writing_or_evaluating_an_RMP\"><\/span>List for writing or evaluating an RMP<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The listed overall parts intended for writing or evaluating the RMP for medicines:<\/p>\n<p>Species of safety<\/p>\n<ul>\n<li>The relevant parts of the safety profiles should be included<\/li>\n<li>The relevant data should be considered when drawing up the safety data sheet<\/li>\n<li>In the event that all parts of the target group have not been studied, it is necessary to include relevant security concerns in relation to potential risks and missing information<\/li>\n<li>Consideration should be given to the limitations in the safety database and the consequences of limitations on the safety profile of the medicinal product<\/li>\n<li>For Reference Medicine applications, all safety issues from the latest RPM must be provided<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Plan_of_Pharmacovigilance\"><\/span>Plan of Pharmacovigilance<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Wole safety issues identified in the safety data sheet must be addressed in the pharmacovigilance plan<\/li>\n<li>Regular pharmacovigilance actions should be sufficient and additional pharmacovigilance actions should be regarded if needed<\/li>\n<li>The actions in the pharmacovigilance plan should be obviously specified, outlined, and appropriate to identify the risks or provide the missing information<\/li>\n<li>Safety studies that have been inflicted by the agency the conditions should be clearly defined<\/li>\n<li>For existed safety considerations related to medication mistakes, the RPM should include appropriate offers for monitoring the correct utilization of the medicine<\/li>\n<li>The offered additional <a href=\"https:\/\/www.kolabtree.com\/blog\/ensuring-reproducibility-in-ai-driven-research-how-freelance-experts-can-help-in-biotech-and-healthcare\/\">research<\/a> must be necessary, attainable, non-advertisable and able of provide the necessary additional specification of the risk and answering scientific questions<\/li>\n<li>Deadlines and milestonesshould be relevant for the proposed action, including the presentation of results<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Post-authorization_efficacy_studies_plan\"><\/span>Post-authorization efficacy studies plan<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>All PAES, either as terms of the approved marketing or as special responsibilities, must be included.<\/li>\n<\/ul>\n<h3><span class=\"ez-toc-section\" id=\"Risk_mitigation_plan\"><\/span>Risk mitigation plan<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<ul>\n<li>Regular risk mitigation measures should be enough, or additional risk mitigation measures should be identified when applicable<\/li>\n<li>If additional measures have been proposed to minimize the risk, they should be adequatelyjustified and proportionate to the risk. Consideration should be given to implementation in all Member States<\/li>\n<li>The criteria for the effectiveness of additional measures to minimize risks must be determined a priori<\/li>\n<li>Methods for assessing the effectiveness of risk mitigation actions should be well described and relevant<\/li>\n<\/ul>\n<h3><span class=\"ez-toc-section\" id=\"Summary_for_Risk_management_plan\"><\/span>Summary for Risk management plan<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<ul>\n<li>RMP submission must be correct<\/li>\n<li>The facts must be presented in an appropriate manner without any advertising elements<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"United_State_FDA_General_quality_Risk_Management_Process\"><\/span><strong>United State (FDA) General quality Risk Management Process<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Quality risk management is a systematic process for the assessment, control, communication and review of risks to the quality of the drug product across the product lifecycle.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Main_Responsibilities\"><\/span><strong>Main Responsibilities<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Quality risk management activities are usually, but not always, undertaken by interdisciplinary teams. When teams are formed, theexperts from the appropriate areas such as quality unit, business development, engineering, regulatory affairs, production operations, sales and marketing, legal, statistics, and clinical must be included in addition to individuals who are knowledgeable about the quality risk management process.<\/p>\n<p>Decision makers should:<\/p>\n<ul>\n<li>take responsibility for coordinating quality risk management across various functions and departments of their organization<\/li>\n<li>ensure that a quality risk management process is defined, deployed, and reviewed and that adequate resources are available<\/li>\n<\/ul>\n<h3><span class=\"ez-toc-section\" id=\"Initiating_a_Quality_Risk_Management_Process_QRMP\"><\/span><strong>Initiating a Quality Risk Management Process (QRMP)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Quality risk management process should include systematic processes designed to coordinate, facilitate and improve science-based decision making with respect to risk. Relevant steps used to initiate and plan a quality risk management process might include the following:<\/p>\n<ul>\n<li>Define the problem and\/or risk question, including pertinent assumptions identifying the potential for risk<\/li>\n<li>Assemble background information and\/or data on the potential hazard, harm or human health impact relevant to the risk assessment<\/li>\n<li>Identify a leader and critical resources<\/li>\n<li>Specify a timeline, deliverables, and appropriate level of decision making for the risk management process<\/li>\n<\/ul>\n<h3><span class=\"ez-toc-section\" id=\"Assessment_for_Risk\"><\/span>Assessment for Risk<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The main role of conducting risk assessment is to identify the risks and assay and evaluate the relevant associated with exposure to those risks. The initiation risk of quality assessments should be started with a clear-cut problem description or question of risk. When the risk in question is clear-cut, an appropriate risk management tool and the types of information that will address the risk question will be in a right away recognizable. As an aid to clearly determining the risk(s) for risk assessment objectives, three basic points are proposed:<\/p>\n<ol>\n<li>To consider what can go in not the right way<\/li>\n<li>Take into consideration the possibility of what can go in not the right way<\/li>\n<li>To monitor the repercussions<\/li>\n<\/ol>\n<p>Identification for Risk is considered as systematic use of information which may help to identify risksthat are referred to the risk question or problem description. Information can include historical data, theoretical analysis, informed opinions, and the concerns of stakeholders. Risk identification addresses the \u201cWhat might go in not the right way?\u201d question, with including the possible consequences that can be identified. This offers the basis for further steps in the quality risk management process.<\/p>\n<p>Analysis for Risk is the qualitative or quantitative process for linking the likelihood of an incident and the strictness of damages. In other words, it is the estimation of the risk associated with the identified hazards.<\/p>\n<p>Evaluation for Risk compares the identified and analyzed risk against given risk criteria. Risk evaluations consider the strength of evidence for all three of the fundamental questions.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Control_for_Risk\"><\/span>Control for Risk<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The aim of risk control is to make decisions which may reduce and\/or accept identified risks. By conducting risk control ideally, the level of identified risk should be reduced to an acceptable level. The amount of effort used for risk control should be proportional to the significance of the risk. Different processes, such as benefit-cost analysis, must be used by decision makers for understanding the optimal level of risk control. For risk control the key points are:<\/p>\n<ul>\n<li>Take into consideration if the risk is above an acceptable level<\/li>\n<li>Actions to reduce or eliminate risks<\/li>\n<li>Identify appropriate balance among benefits, risks and resources<\/li>\n<li>Decide whether new risks are introduced as a result of the identified risks being controlled<\/li>\n<\/ul>\n<h3><span class=\"ez-toc-section\" id=\"Communication_for_Risk\"><\/span>Communication for Risk<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Risk communication is about sharing of the information related to risk and risk management between the decision makers and others. Communication can be at any stage of the risk management process. The output\/result of the quality risk management process should be appropriately communicated and documented. Communications might include those among interested parties (e.g., regulators and industry; industry and the patient; within a company, industry, or regulatory authority). The included information might relate to the existence, nature, form, probability, severity, acceptability, control, treatment, detectability, or other aspects of risks to quality. Communication need not be carried out for each and every risk acceptance. Between the industry and regulatory authorities, communication concerning quality risk management decisions might be affected through existing channels as specified in regulations and guidance\u2019s.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Review_for_Risk\"><\/span>Review for Risk<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>A mechanism to review or monitor events should be implemented. The output\/results of the risk management process should be reviewed to take into account new knowledge and experience.The frequency of any review should be based upon the level of risk. Risk review might include reconsideration of risk acceptance decisions.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Management_methodology_of_risk\"><\/span><strong>Management methodology of risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Basically, quality risk management supports a scientific and practical approach to decision making. It provides documented, transparent, and reproducible methods to accomplish steps of the quality risk management process based on current knowledge about assessing the probability, severity, and, sometimes, detectability of the risk. Traditionally, risks to quality have been assessed and managed in a variety of informal ways (empirical and\/or internal procedures) based on, for example, compilation of observations, trends, and other information.<\/p>\n<p>In addition, the pharmaceutical industry and regulators can assess and manage risk using recognized risk management tools and\/or internal procedures (e.g., standard operating procedures).<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Management_methods_and_tools_of_risk\"><\/span><strong>Management methods and tools of risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>This section included as an aid to gain more knowledge and detail about the particular tool. Important to note that no single tool or toolbox is applicable to every situation in which a quality risk management procedure is used.Each company-specific requirement can be provided in the format.<\/p>\n<p><em>Basic Risk Management Facilitation Methods <\/em><\/p>\n<p>Here are some of the simple techniques commonly used to structure risk management by organizing data and facilitating decision making:<\/p>\n<ul>\n<li>Flowcharts<\/li>\n<li>Check Sheets<\/li>\n<li>Process Mapping<\/li>\n<li>Cause and Effect Diagrams (also called an Ishikawa diagram or fish bone diagram).<\/li>\n<\/ul>\n<p><strong>__________<br \/>\nNeed help to prepare a risk management plan? Consult <a href=\"https:\/\/www.kolabtree.com\/find-an-expert\/subject\/regulatory-writing?utm_source=Blog&amp;utm_medium=Post&amp;utm_campaign=RMP\">regulatory affairs experts<\/a> and <a href=\"https:\/\/www.kolabtree.com\/find-an-expert\/subject\/medical-writing\/?utm_source=Blog&amp;utm_medium=Post&amp;utm_campaign=RMP\">medical writers<\/a> on Kolabtree.<\/strong><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nare Simonyan, freelance regulatory affairs specialist at Kolabtree, provides a comprehensive guide to preparing a Risk Management Plan (RMP). Abbreviations RMP &#8211; Risk Management Plan aPV &#8211; additional Pharmacovigilance eCTD &#8211; electronic Common Technical Document PSUR- Periodic Safety Update Report PASS &#8211; Post-Authorization Safety Studies PAES &#8211; Plans Post-authorization Efficacy Studies RA- Regulatory Authority QRMP<\/p>\n<div class=\"read-more\"><a href=\"https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/\" title=\"Read More\">Read More<\/a><\/div>\n","protected":false},"author":12,"featured_media":9321,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[147],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.1 (Yoast SEO v20.1) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>How to prepare a Risk Management Plan (RMP): An essential guide<\/title>\n<meta name=\"description\" content=\"How to prepare a risk management plan (RMP), based on FDA and EU requirements, specific to the pharma and medical device markets.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to prepare a Risk Management Plan (RMP): An essential guide\" \/>\n<meta property=\"og:description\" content=\"How to prepare a risk management plan (RMP), based on FDA and EU requirements, specific to the pharma and medical device markets.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/\" \/>\n<meta property=\"og:site_name\" content=\"The Kolabtree Blog\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/kolabtree\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-28T16:37:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-02-15T11:44:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.kolabtree.com\/blog\/wp-content\/uploads\/2021\/07\/close-up-detail-team-working-o-new-project-coworking-space-writing-ideas-looking-through-graphics-tablet-laptop-teamwork-business-concept.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"667\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Ramya Sriram\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@kolabtree\" \/>\n<meta name=\"twitter:site\" content=\"@kolabtree\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ramya Sriram\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to prepare a Risk Management Plan (RMP): An essential guide","description":"How to prepare a risk management plan (RMP), based on FDA and EU requirements, specific to the pharma and medical device markets.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/","og_locale":"en_US","og_type":"article","og_title":"How to prepare a Risk Management Plan (RMP): An essential guide","og_description":"How to prepare a risk management plan (RMP), based on FDA and EU requirements, specific to the pharma and medical device markets.","og_url":"https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/","og_site_name":"The Kolabtree Blog","article_publisher":"https:\/\/www.facebook.com\/kolabtree","article_published_time":"2021-07-28T16:37:47+00:00","article_modified_time":"2023-02-15T11:44:54+00:00","og_image":[{"width":1000,"height":667,"url":"https:\/\/www.kolabtree.com\/blog\/wp-content\/uploads\/2021\/07\/close-up-detail-team-working-o-new-project-coworking-space-writing-ideas-looking-through-graphics-tablet-laptop-teamwork-business-concept.jpg","type":"image\/jpeg"}],"author":"Ramya Sriram","twitter_card":"summary_large_image","twitter_creator":"@kolabtree","twitter_site":"@kolabtree","twitter_misc":{"Written by":"Ramya Sriram","Est. reading time":"9 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/#article","isPartOf":{"@id":"https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/"},"author":{"name":"Ramya Sriram","@id":"https:\/\/www.kolabtree.com\/blog\/#\/schema\/person\/81992f5863a1b06d132a47822e7b4400"},"headline":"How to prepare a Risk Management Plan (RMP): An essential guide","datePublished":"2021-07-28T16:37:47+00:00","dateModified":"2023-02-15T11:44:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/"},"wordCount":1967,"commentCount":0,"publisher":{"@id":"https:\/\/www.kolabtree.com\/blog\/#organization"},"articleSection":["Writing"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/","url":"https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/","name":"How to prepare a Risk Management Plan (RMP): An essential guide","isPartOf":{"@id":"https:\/\/www.kolabtree.com\/blog\/#website"},"datePublished":"2021-07-28T16:37:47+00:00","dateModified":"2023-02-15T11:44:54+00:00","description":"How to prepare a risk management plan (RMP), based on FDA and EU requirements, specific to the pharma and medical device markets.","breadcrumb":{"@id":"https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.kolabtree.com\/blog\/how-to-prepare-a-risk-management-plan-rmp-an-essential-guide\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.kolabtree.com\/blog\/"},{"@type":"ListItem","position":2,"name":"How to prepare a Risk Management Plan (RMP): An essential guide"}]},{"@type":"WebSite","@id":"https:\/\/www.kolabtree.com\/blog\/#website","url":"https:\/\/www.kolabtree.com\/blog\/","name":"The Kolabtree Blog","description":"Expert Views on Science, Innovation and Product Development","publisher":{"@id":"https:\/\/www.kolabtree.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.kolabtree.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.kolabtree.com\/blog\/#organization","name":"Kolabtree","url":"https:\/\/www.kolabtree.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.kolabtree.com\/blog\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Kolabtree"},"image":{"@id":"https:\/\/www.kolabtree.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/kolabtree","https:\/\/twitter.com\/kolabtree","https:\/\/instagram.com\/kolabtree","https:\/\/www.linkedin.com\/company\/kolabtree","https:\/\/en.m.wikipedia.org\/wiki\/Kolabtree"]},{"@type":"Person","@id":"https:\/\/www.kolabtree.com\/blog\/#\/schema\/person\/81992f5863a1b06d132a47822e7b4400","name":"Ramya Sriram","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.kolabtree.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/8100b45c960ebbbbe420e8b3f250515f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8100b45c960ebbbbe420e8b3f250515f?s=96&d=mm&r=g","caption":"Ramya Sriram"},"description":"Ramya Sriram manages digital content and communications at Kolabtree (kolabtree.com), the world's largest freelancing platform for scientists. She has over a decade of experience in publishing, advertising and digital content creation.","url":"https:\/\/www.kolabtree.com\/blog\/author\/ramyas\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.kolabtree.com\/blog\/wp-json\/wp\/v2\/posts\/9226"}],"collection":[{"href":"https:\/\/www.kolabtree.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.kolabtree.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.kolabtree.com\/blog\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/www.kolabtree.com\/blog\/wp-json\/wp\/v2\/comments?post=9226"}],"version-history":[{"count":4,"href":"https:\/\/www.kolabtree.com\/blog\/wp-json\/wp\/v2\/posts\/9226\/revisions"}],"predecessor-version":[{"id":10461,"href":"https:\/\/www.kolabtree.com\/blog\/wp-json\/wp\/v2\/posts\/9226\/revisions\/10461"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.kolabtree.com\/blog\/wp-json\/wp\/v2\/media\/9321"}],"wp:attachment":[{"href":"https:\/\/www.kolabtree.com\/blog\/wp-json\/wp\/v2\/media?parent=9226"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.kolabtree.com\/blog\/wp-json\/wp\/v2\/categories?post=9226"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.kolabtree.com\/blog\/wp-json\/wp\/v2\/tags?post=9226"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}